Group Head
Dr Campbell Aitken
Staff
Margaret Hellard
Mark Stoové
Peter Higgs
Duyen Duong
Rachel Sacks-Davis
Rebecca Winter
Sally Von Bibra
Oanh Nguyen
Research Interests
An estimated 170 million people are infected with the hepatitis C virus. Hepatitis C is associated with considerable mortality and morbidity, particularly due to cirrhosis of the liver and liver cancer. The Centre’s research focuses on improving understanding about hepatitis C virus infection and transmission, with the ultimate aim of developing a hepatitis C vaccine. Staff at the Centre for Population Health conduct innovative studies involving people who inject drugs (the group most at risk of infection with the hepatitis C virus) and collaborate with virologists, immunologists and mathematical modellers in Australia and worldwide.
Current Projects
- The Australian Trial for Acute Hepatitis C (ATAHC)
- Immunological, virological and behavioural factors influencing HCV among IDUs (Networks II)
- An investigation of factors allowing some injecting drug users to avoid Hepatitis C virus exposure